Janux Therapeutics Inc's total assets for Q3 2025 were $1.02B, a decrease of -0.72% from the previous quarter. JANX total liabilities were $48.21M for the fiscal quarter, a 15.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.